Lakewood-Amedex, Inc. Patent Portfolio Summary

Patent Family 1
Country Title Application No. Patent No. Status Expiry Date
Australia Pulmonary Delivery of Protonated/Acidified Nucleic Acids 2002305336 AU2002305336 In Force 5/3/22
Australia Antimicrobial and Antiviral Compounds and Methods for Their Use 2013276985 AU2013276985 In Force 5/3/22
Belgium Antimicrobial Compounds and Methods for Their Use 10184218.5 EP2311466 In Force 5/3/22
Canada Antimicrobial Compounds and Methods for Their Use 2445381 CA2445381 In Force 5/3/22
Canada Phosphorous Containing Antimicrobial Compounds and Methods for Their Use 2827671 CA2827671 In Force 5/3/22
Denmark Antimicrobial Compounds and Methods for Their Use 10184218.5 EP2311466 In Force 5/3/22
European Patent Convention Antimicrobial Compounds and Methods for Their Use 2734149.4 EP1389909 Granted 5/3/22
European Patent Convention Antimicrobial Compounds and Methods for Their Use 10184218.5 EP2311466 Granted 5/3/22
France Antimicrobial Compounds and Methods for Their Use 10184218.5 EP2311466 In Force 5/3/22
France Antimicrobial Compounds and Methods for Their Use 2734149.4 EP1389909 In Force 5/3/22
Germany Antimicrobial Compounds and Methods for Their Use 10184218.5 EP2311466 In Force 5/3/22
Germany Antimicrobial Compounds and Methods for Their Use 2734149.4 EP1389909 In Force 5/3/22
Greece Antimicrobial Compounds and Methods for Their Use 10184218.5 EP2311466 In Force 5/3/22
Ireland Antimicrobial Compounds and Methods for Their Use 10184218.5 EP2311466 In Force 5/3/22
Ireland Antimicrobial Compounds and Methods for Their Use 2734149.4 EP1389909 In Force 5/3/22
Italy Antimicrobial Compounds and Methods for Their Use 10184218.5 EP2311466 In Force 5/3/22
Japan Pulmonary Delivery of Protonated/Acidified Nucleic Acids 2000-607640 JP4883840 In Force 3/28/20
Japan Antimicrobial Compounds and Methods for Their Use 2002-586732 JP4347573 In Force 5/3/22
Japan Antimicrobial Compounds and Methods for Their Use 2009-120362 JP5503900 In Force 5/3/22
Japan Antimicrobial Compounds and Methods for Their Use 2013-210031 JP5883838 In Force 5/3/22
Japan Protonated/Acidified Nucleic Acids and Methods of Use 2015-219286  JP6097372 In Force 5/3/22
Liechtenstein Antimicrobial Compounds and Methods for Their Use 10184218.5 EP2311466 In Force 5/3/22
Netherlands Antimicrobial Compounds and Methods for Their Use 10184218.5 EP2311466 In Force 5/3/22
Netherlands Antimicrobial Compounds and Methods for Their Use 2734149.4 EP1389909 In Force 5/3/22
Portugal Antimicrobial Compounds and Methods for Their Use 10184218.5 EP2311466 In Force 5/3/22
Spain Antimicrobial Compounds and Methods for Their Use 10184218.5 EP2311466 In Force 5/3/22
Sweden Antimicrobial Compounds and Methods for Their Use 10184218.5 EP2311466 In Force 5/3/22
Sweden Antimicrobial Compounds and Methods for Their Use 2734149.4 EP1389909 In Force 5/3/22
Switzerland Antimicrobial Compounds and Methods for Their Use 10184218.5 EP2311466 In Force 5/3/22
Switzerland Antimicrobial Compounds and Methods for Their Use 2734149.4 EP1389909 In Force 5/3/22
United Kingdom Antimicrobial Compounds and Methods for Their Use 10184218.5 EP2311466 In Force 5/3/22
United Kingdom Antimicrobial Compounds and Methods for Their Use 2734149.4 EP1389909 In Force 5/3/22
United States Devices for Improved Wound Management 09/281858 US6627215 In Force 12/30/18
United States Pulmonary Delivery of Protonated/Acidified Nucleic Acids 09/282824 US6211162 In Force 12/30/18
United States Antimicrobial and Antiviral Compounds and Methods for Their Use 11/552951 US7868162 In Force 06/03/21[1]
United States Antimicrobial Compounds and Methods for Their Use 10/937094 US7176191 In Force 12/30/18
United States Devices for Improved Wound Management 12/130405 US8435960 In Force 12/30/18
United States Protonated/Acidified Nucleic Acids and Methods of Use 09/222009 US6211349 In Force 12/30/18
[1] This patent is subject to 886 days of Patent Term Adjustment.
Patent Family 2
Country Title Application No. Patent No. Status Expiry Date
Canada Acid Stable Backbone Modified End-Blocked Nucleic Acids and Therapeutic Uses Thereof 2357986 CA2357986 In Force 12/16/19
United States Arrays with Modified Oligonucleotide and Polynucleotide Compositions 09/408088 US6087112 In Force 12/30/18
United States Arrays with Modified Oligonucleotide and Polynucleotide Compositions 09/524092 US6562569 In Force 12/30/18
United States Arrays with Modified Oligonucleotide and Polynucleotide Compositions 09/528404 US6440723 In Force 12/30/18
Patent Family 3
Country Title Application No. Patent No. Status Expiry Date
European Patent Convention Therapeutic Phosphodiesterase Inhibitors 99968130.7 EP1141278 Granted 12/15/19
Japan Therapeutic Phosphodiesterase Inhibitors 2000-592411 JP4787409 In Force 12/15/19
Patent Family 4
Country Title Application No. Patent No. Status Expiry Date
China Oligonucleotide-Containing Pharmacological Compositions and Their Use 2813802.3 CN100344646 In Force 7/10/22
European Patent Convention Oligonucleotide-Containing Pharmacological Compositions and Their Use 2749875.7 EP1414841 Granted 7/10/22
France Oligonucleotide-Containing Pharmacological Compositions and Their Use 2749875.7 EP1414841 In Force 7/10/22
Germany Oligonucleotide-Containing Pharmacological Compositions and Their Use 2749875.7 EP1414841 In Force 7/10/22
Ireland Oligonucleotide-Containing Pharmacological Compositions and Their Use 2749875.7 EP1414841 In Force 7/10/22
Israel Oligonucleotide-Containing Pharmacological Compositions and Their Use 159722 IL159722 In Force 7/10/22
Japan Oligonucleotide-Containing Pharmacological Compositions and Their Use 2003-512248 JP4999255 In Force 7/10/22
United Kingdom Oligonucleotide-Containing Pharmacological Compositions and Their Use 2749875.7 EP1414841 In Force 7/10/22
United States Oligonucleotide-Containing Pharmacological Compositions and Their Use 11/673486 US8916529 In Force 10/29/24[2]
United States Oligonucleotide-Containing Pharmacological Compositions and Their Use 11/673508 US8188259 In Force 01/19/23[3]
United States Oligonucleotide-Containing Pharmacological Compositions and Their Use 11/673509 US8183361 In Force 02/23/23[4]
United States Oligonucleotide-Containing Pharmacological Compositions and Their Use 14/534901 US9567584 In Force 7/10/22
[2] This patent is subject to 842 days of Patent Term Adjustment.
[3] This patent is subject to 193 days of Patent Term Adjustment.
[4] This patent is subject to 228 days of Patent Term Adjustment.
Patent Family 5
Country Title Application No. Patent No. Status Expiry Date
Australia Compositions and Methods for the Treatment of Muscle Wasting 2006345724 AU2006345724 In Force 6/30/26
Canada Compositions and Methods for the Treatment of Muscle Wasting 2558160 CA2558160 In Force 6/30/26
China Compositions and Methods for the Treatment of Muscle Wasting 200510077730.2 CN100393320 In Force 6/24/25
United Kingdom Compositions and Methods for the Treatment of Muscle Wasting 616790.2 GB2441581 In Force 6/30/26
United States Compositions and Methods for the Treatment of Muscle Wasting 11/479112 US8097596 In Force 08/11/29[5]
[5] This patent is subject to 1138 days of Patent Term Adjustment.
Patent Family 6
Country Title Application No. Patent No. Status Expiry Date
China Compositions and Methods for the Treatment of Influenza Infection 200610000900.1 CN100562342 In Force 1/17/26
United States Compositions and Methods for the Treatment of Influenza Infection 11/458378 US9574243 In Force 09/21/30[6]
United States Compositions and Methods for the Treatment of Influenza Infection 15/400,797 Pending
[6] This patent is subject to 1526 days of Patent Term Adjustment.
Patent Family 7
Country Title Application No. Patent No. Status Expiry Date
PCT Antimicrobial Compounds, Compositions, and Uses Thereof PCT/US18/22068 Pending
PCT Antimicrobial Compounds, Compositions, and Uses Thereof PCT/US18/22071 Pending
United States Antimicrobial Compounds, Compositions, and Uses Thereof 15/919,138 Pending
Patent Family 8
Country Title Application No. Patent No. Status Expiry Date
United States Bisphosphocin Gel Formulations 62/518,262 Filed June 12, 2017